The role of the DRY motif of human MC4R for receptor activation

Bioscience, Biotechnology and Biochemistry

Volumn 68, Issue 6, 2004, Pages 1369-1371

  Yamano, Yoshiaki ^a   Kamon, Rio ^a   Yoshimizu, Takao ^b   Toda, Yoshihisa ^b   Oshida, Yuichi ^b   Chaki, Shigeyuki ^b   Yoshioka, Masanobu ^a   Morishima, Isao ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

cAMP; DRY motif; G protein coupled receptor; Melanocortin type 4 receptor; Site directed mutagenesis

Indexed keywords

CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; LIGAND; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN COS1; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; PHYSIOLOGY; PROTEIN BINDING; PROTEIN MOTIF; SITE DIRECTED MUTAGENESIS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; COS CELLS; CYCLIC AMP; HUMANS; LIGANDS; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PROTEIN BINDING; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, G-PROTEIN-COUPLED; TRANSFECTION;

EID: 4544274062     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.68.1369     Document Type: Article

References (17)

1. Von Frijtag, J. C., Croiset, G., Gispen, W. H., Adan, R. A., and Wiegant, V. M., The role of central melanocortin receptors in the activation of the hypothalamus-pituitary-adrenal-axis and the induction of excessive grooming. Br. J. Pharmacol., 123, 1503-1508 (1998).
2. Gonzalez, M. I., Vaziri, S., and Wilson, C. A., Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides, 17, 171-177 (1996).
3. Corda, M. G., Orlandi, M., and Fratta, W., Proconflict effect of ACTH1-24: interaction with benzodiazepines. Pharmacol. Biochem. Behav., 36, 631-634 (1990).
4. Alvaro, J. D., Tatro, J. B., Quillan, J. M., Fogliano, M., Eisenhard, M., Lerner, M. R., Nestler, E. J., and Duman, R. S., Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol. Pharmacol., 50, 583-591 (1996).
5. Adan, R. A., Szklarczyk, A. W., Oosterom, J., Brakkee, J. H., Nijenhuis, W. A., Schaaper, W. M., Meloen, R. H., and Gispen, W. H., Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat. Eur. J. Pharmacol., 378, 249-258 (1999).
6. Mountjoy, K. G., Mortrud, M. T., Low, M. J., Simerly, R. B., and Cone, R. D., Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol., 8, 1298-1308 (1994).
7. Lubrano-Berthelier, C., Cavazos, M., Dubern, B., Shapiro, A., Stunff, C. L., Zhang, S., Picart, F., Govaerts, C., Froguel, P., Bougneres, P., Clement, K., and Vaisse, C., Molecular genetics of human obesity-associated MC4R mutations. Ann. N.Y. Acad. Sci., 994, 49-57 (2003).
8. Chaki, S., Hirota, S., Funakoshi, T., Suzuki, Y., Suetake, S., Okubo, T., Ishii, T., Nakazato, A., and Okuyama, S., Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4- isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. J. Pharmacol. Exp. Ther., 304, 818-826 (2003).
9. 1 angiotensin receptor activation and signaling. Endocrinology, 144, 2220-2228 (2003).
10. Chen, A., Gao, Z. G., Barak, D., Liang, B. T., and Jacobson, K. A., Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis to create constitutively active mutant human A(3) adenosine receptors (ARs). Biochem. Biophys. Res. Commun., 284, 596-601 (2001).
11. Scheer, A., Costa, T., Fanelli, F., De Benedetti, P. G., Mhaouty-Kodja, S., Abuin, L., Nenniger-Tosato, M., and Cotecchia, S., Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation. Mol. Pharmacol., 57, 219-231 (2000).
12. Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G., and Cotecchia, S., Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J., 15, 3566-3578 (1996).
13. Morin, D., Cotte, N., Balestre, M. N., Mouillac, B., Manning, M., Breton, C., and Barberis, C., The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett., 441, 470-475 (1998).
14. Alewijnse, A. E., Timmerman, H., Jacobs, E. H., Smit, M. J., Roovers, E., Cotecchia, S., and Leurs, R., The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol. Pharmacol., 57, 890-898 (2000).
15. Haskell-Luevano, C., and Monck, E. K., Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept., 99, 1-7 (2001).
16. Haskell-Luevano, C., Cone, R. D., Monck, E. K., and Wan, Y. P., Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochem., 40, 6164-6179 (2001).
17. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., and Yamada, T. J., Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem., 268, 15174-15179 (1993).